for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

FDA narrows label for Biogen’s Alzheimer’s drug

[NFA] Biogen said on Thursday the U.S. Food and Drug Administration has approved changes to product information on its Alzheimer's disease drug, effectively narrowing the target population. Fred Katayama reports.

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up